Chiropractors in Plainview, MN Accepting Medicare
7 Chiropractors found. Showing 1 - 7
 Dr. Judd A Stucky, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 349 West Broadway, Plainview, MN 55964 Phone: 507-534-3502 |
 Dr. Nicholle Diane Corcoran, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 323 W Broadway, Plainview, MN 55964 Phone: 507-534-2600 |
Dr. James D Hiebert, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 323 W Broadway, Plainview, MN 55964 Phone: 507-534-2600 Fax: 507-534-4373 |
Dr. James Leo Stucky, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 349 West Broadway, Plainview, MN 55964 Phone: 507-534-3502 |
Dr. Melissa Sue Nevsimal, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 323 W Broadway, Plainview, MN 55964 Phone: 507-534-2600 Fax: 507-534-4373 |
Dr. Marcy Vreeman, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 323 W Broadway, Plainview, MN 55964 Phone: 507-534-2600 Fax: 507-534-4373 |
 Dr J L Stucky Chiropractor Pa Chiropractor Medicare: Medicare Enrolled Practice Location: 349 West Broadway, Plainview, MN 55964 Phone: 507-534-3502 |
News Archive
Scientists create 'immunoswitch' particles that slow cancer growth in test animals
Scientists at Johns Hopkins have created a nanoparticle that carries two different antibodies capable of simultaneously switching off cancer cells' defensive properties while switching on a robust anticancer immune response in mice.
EDEMA4 study results of KALBITOR for treatment of acute attacks of HAE published
Dyax Corp. announced today the publication of results from its second Phase 3, placebo-controlled trial, known as EDEMA4, evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema. The results, published in the June 2010 issue of the Annals of Allergy, Asthma, and Immunology, indicate that KALBITOR is effective in ameliorating HAE attacks, resolving associated symptoms and preventing attack progression.
Soligenix signs common stock purchase agreements with existing and new investors
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that it has entered into common stock purchase agreements with both existing and new investors totaling approximately $5.16 million. Soligenix's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Study reveals why SARS-CoV-2 is more infectious than SARS-CoV-1
Researchers from China and Canada recently combined structural data obtained from cryo-EM and structure prediction and constructed bottom-up Martini coarse-grained models of intact envelopes of SARS-CoV and SARS-CoV-2.
N.C. Gov. Vetoes abortion bill; 2 Kansas doctors file suit against Kansas law; R.I. exchange bill caught in dispute
Gov. Bev Perdue vetoed a bill Monday that would require women seeking abortions to wait 24 hours after state-prescribed counseling, leaving the bill's House supporters looking for override votes. The bill would have made significant changes in state abortion policy, changes supporters said would give pregnant women important information about fetal development and abortion alternatives.
› Verified 8 days ago